| scholarly article | Q13442814 |
| P50 | author | Ming-Lung Yu | Q57002538 |
| Tomer Meirson | Q41045081 | ||
| Gur Yaari | Q41050662 | ||
| Assam El-osta | Q43160132 | ||
| P2093 | author name string | Raymond T Chung | |
| Meital Gal-Tanamy | |||
| Chia-Yen Dai | |||
| Antony Kaspi | |||
| Izhak Haviv | |||
| Chung-Feng Huang | |||
| Salomon M Stemmer | |||
| Ateret Davidovich | |||
| Jacinta Alison Holmes | |||
| Anat Lavi-Itzkovitz | |||
| Shira Perez | |||
| Assy Nimer | |||
| Tom Domovitz | |||
| P2860 | cites work | Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 |
| NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations | Q26745576 | ||
| Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy | Q26795750 | ||
| Molecular determinants and dynamics of hepatitis C virus secretion | Q27347838 | ||
| Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus | Q27478033 | ||
| CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes | Q27486789 | ||
| Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles | Q27489056 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| Replication of hepatitis C virus | Q27860957 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
| BEDTools: a flexible suite of utilities for comparing genomic features | Q29547332 | ||
| STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
| Knowledge-based analysis of proteomics data | Q30578329 | ||
| Chromatin at the intersection of viral infection and DNA damage | Q33729186 | ||
| Mechanisms of epigenetic memory | Q33810523 | ||
| Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma | Q33863710 | ||
| Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle | Q33893794 | ||
| Viral hit and run-oncogenesis: Genetic and epigenetic scenarios | Q34135741 | ||
| Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? | Q34358742 | ||
| featureCounts: an efficient general purpose program for assigning sequence reads to genomic features | Q34384848 | ||
| An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. | Q34670759 | ||
| Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells | Q35451716 | ||
| Cell-of-origin chromatin organization shapes the mutational landscape of cancer | Q35510462 | ||
| Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies. | Q35565927 | ||
| Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy. | Q52332749 | ||
| "Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study". | Q52649962 | ||
| Molecular Pathways: The Complexity of the Epigenome in Cancer and Recent Clinical Advances | Q58862228 | ||
| Is hepatitis C virus carcinogenic? | Q35576656 | ||
| Altering cancer transcriptomes using epigenomic inhibitors | Q35863203 | ||
| Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts | Q36214096 | ||
| How do persistent infections with hepatitis C virus cause liver cancer? | Q36236839 | ||
| Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals | Q36306768 | ||
| Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes | Q36414367 | ||
| Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair | Q36565849 | ||
| Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis | Q36788468 | ||
| Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia | Q36916418 | ||
| EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy | Q37609988 | ||
| Exploring the genomes of cancer cells: progress and promise | Q37857590 | ||
| Epigenetic memory in the context of nuclear reprogramming and cancer | Q38098977 | ||
| Mechanisms underlying mutational signatures in human cancers | Q38225013 | ||
| Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection | Q38355057 | ||
| Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition | Q38726399 | ||
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study | Q38839762 | ||
| A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene. | Q38848401 | ||
| Hepatitis virus infection affects DNA methylation in mice with humanized livers. | Q39067748 | ||
| Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers. | Q39138235 | ||
| Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion | Q39246449 | ||
| Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis | Q39523228 | ||
| Signalome-wide assessment of host cell response to hepatitis C virus | Q40211267 | ||
| Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature. | Q40252283 | ||
| A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets | Q40512450 | ||
| Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C. | Q40523304 | ||
| Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment | Q41082823 | ||
| An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. | Q41665498 | ||
| Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro | Q42143878 | ||
| Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase | Q42454464 | ||
| Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. | Q42994110 | ||
| Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals. | Q47590714 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | edgeR | Q113334690 |
| P433 | issue | 6 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | e1008181 | |
| P577 | publication date | 2019-06-19 | |
| P1433 | published in | PLOS Genetics | Q1893441 |
| P1476 | title | Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals | |
| P478 | volume | 15 |
| Q92441611 | Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host Factors |
| Q106624325 | Genome‐wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID‐19 |
| Q90228670 | Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression |
| Q94453487 | Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment |
| Q90387894 | Synergistic lethal mutagenesis of hepatitis C virus |
| Q90689008 | Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma |
| Q89860205 | The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm |
| Q90434504 | Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy |
Search more.